Case Studies
HEALTHCArE
GLP-1 Drug Market Analysis
Quarterly claims data reveals the explosive growth of GLP-1 drugs — who's prescribing, who's paying, and where the market is heading.
In a concerning trend, a growing number of older adults find themselves compelled to make agonizing choices, sacrificing fundamental necessities to cope with the escalating burden of healthcare costs.
Read Story